
IndraLab
Statements
sparser
"Our studies demonstrate a primary LQT-3 (Na + channel) defect not influenced by the KCNH2 polymorphism and drug interactions unique to the proband that correlate with improved management of arrhythmias in the patient and provide support for this approach in developing patient-specific clinical regimens."